Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Combat Medical is a specialized medical technology company focused on improving outcomes for patients with non-muscle invasive bladder cancer (NMIBC). The company's flagship technology, the Combat BRS (Bladder Recirculation System), delivers Hyperthermic Intra-VEsical Chemotherapy (HIVEC), which uses heat to enhance the effectiveness of chemotherapy drugs within the bladder. By maintaining a precise temperature and recirculating the chemotherapy solution, the system increases drug absorption and targets cancer cells more effectively than traditional room-temperature treatments. Combat Medical's solutions are used globally in clinical practice and are supported by extensive clinical research aimed at reducing cancer recurrence and progression. The company is headquartered in the United Kingdom and operates as a key player in the urological oncology space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Combat Arena.